Accordingly, dysregulation of the mevalonate pathway in tumors was shown to cause activation of Vγ9Vδ2+ T cells via IPP accumulation (37) and induced γδ T-cell chemotaxis toward tumor cells (38, 39). The gene discussed is IPP; the disease is neoplasm.